TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

PHYTRICARE

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

PHYTRICARE

ST13

US500000079366121

Classe

5, 31

Pedido

79366121

Registro

7445250

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

35

Atualização mais recente

17/01/2025

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

5, 31

Data de depósito

29/11/2022

Data de registro

16/07/2024

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

16/07/2024

Última transação

17/01/2025

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

16

Localização do titular

DE

Examinador

HAN, DAWN

Localização atual

FILE REPOSITORY (FRANCONIA)

Titulares e representantes

Titulares

Evonik Operations GmbH

Representantes

Scott D. Woldow Smith, Gambrell & Russell, LLP

Classificação técnica

Classes Nice

Classe 5Classe 31

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

Pharmaceutical preparations for treating inflammation conditions and metabolic conditions; pharmaceutical preparations for nutrition, namely, nutritional supplements; veterinary preparations for treating inflammation conditions and metabolic conditions; veterinary preparations for nutrition, namely, nutritional supplements for veterinary purposes; medical preparations for the treatment of inflammation conditions and metabolic conditions; medical preparations for nutrition chemical preparations for nutrition, namely, nutritional supplements for medical purposes; medicated additives for animal foods, namely, animal feed additives for use as nutritional supplements for medical purposes; additives with medicinal effects for feed, namely, animal feed additives for use as nutritional supplements for medical purposes; chemical preparations for inflammation conditions and metabolic conditions for medical, pharmaceutical and veterinary purposes; chemical preparations for nutrition, namely, nutritional supplements for medical, pharmaceutical and veterinary purposes; medicated animal feed; medicated supplements for animal feedstuffs; amino acids for medical and veterinary purposes; cellulose esters for pharmaceutical purposes, medicinal oils and greases for medical and veterinary purposes; salt products, namely, potassium iodide and sodium salts for medical purposes; steroids; biological preparations for the treatment of metabolic disorders for medical and veterinary purposes; ferments for pharmaceutical purposes; yeast dietary supplements; yeast for pharmaceutical purposes; starch for pharmaceutical purposes; enzymes and enzyme preparations, all for medical and veterinary purposes; bacterial preparations for medical and veterinary purposes; bacteriological preparations for medical and veterinary purposes; cultures of microorganisms for medical and veterinary use; nutritive substances for microorganisms for medical purposes; bouillons for bacteriological cultures for medical or veterinary purposes; probiotic supplements; probiotic bacterial preparations for veterinary use; probiotic preparations for medical use featuring bacterial formulations; probiotic supplements for dietetic use; food supplements in the nature of antioxidants; sanitary preparations for medical purposes; dietetic foods adapted for medical and veterinary use; dietetic preparations adapted for medical purposes; dietetic animal foodstuffs for medical purposes; nutritional supplements; albuminous dietetic preparations adapted for medical purposes; medicated confectionery; medicinal drinks; dietetic beverages adapted for medical purposes; dietetic preparations adapted for medical use; medical preparations for slimming purposes; nutritional supplements for humans; dietary supplements for animals; dietetic preparations adapted for medical purposes and for use as dietary supplements; sugar in the nature of candy and glucose for medical purposes; glucose for medical purposes; dietetic albuminous animal foodstuffs for medical purposes; protein dietary supplements; dietary fibre to aid digestion; mineral food supplements; nutritional preparations, namely, nutritional supplements containing trace elements for human and animal use; vitamin preparations; feed supplements in the nature of amino acids for veterinary purposes, synthetic peptides for the treatment of inflammation, metabolic conditions, nutrition deficiency, and protein supplements for use in animal feed, fish food and aquacultures; animal feed supplements, not for medical purposes; nutritional supplements, namely, flavonoids for use as a dietary supplement

Classe 31

Products for aquaculture, namely, aquaculture feed; live animals; foodstuffs and fodder for animals; preparations for use as animal feed; foodstuffs for fish; aquaculture feed; foodstuffs for animals containing botanical extracts; yeast for animal consumption

Publicações

Histórico de despachos e eventos da marca no USPTO.

35 publicações encontradas

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

17/01/2025

FICS

FINAL DISPOSITION NOTICE SENT TO IB

27/12/2024

FIMP

FINAL DISPOSITION PROCESSED

27/12/2024

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

17/10/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

16/07/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

16/07/2024

GPNX

NOTIFICATION PROCESSED BY IB

30/04/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

30/04/2024

PUBO

PUBLISHED FOR OPPOSITION

30/04/2024

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

10/04/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

10/04/2024

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

10/04/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

25/03/2024

XAEC

EXAMINER'S AMENDMENT ENTERED

25/03/2024

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

25/03/2024

GNEA

EXAMINERS AMENDMENT E-MAILED

25/03/2024

CNEA

EXAMINERS AMENDMENT -WRITTEN

25/03/2024

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

18/03/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

18/03/2024

XAEC

EXAMINER'S AMENDMENT ENTERED

18/03/2024

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

18/03/2024

GNEA

EXAMINERS AMENDMENT E-MAILED

18/03/2024

CNEA

EXAMINERS AMENDMENT -WRITTEN

18/03/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

18/01/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

18/01/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

18/01/2024

RFNT

REFUSAL PROCESSED BY IB

29/08/2023

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

04/08/2023

RFRR

REFUSAL PROCESSED BY MPU

04/08/2023

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

28/06/2023

CNRT

NON-FINAL ACTION WRITTEN

27/06/2023

DOCK

ASSIGNED TO EXAMINER

19/06/2023

MAFR

APPLICATION FILING RECEIPT MAILED

04/04/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

31/03/2023

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

30/03/2023

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace PHYTRICARE ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.